Abstract
Psychosocial health predicts and contributes to medical outcomes for patients undergoing hematopoietic stem cell transplantation (HSCT). Yet, there are no standards for psychosocial assessments or support for both patients and caregivers across the care continuum. To examine the current state of psychosocial care, clinicians were sent a survey of their psychosocial assessment practices for patients and caregivers undergoing HSCT via the Listservs of professional organizations. Descriptive statistics and bivariate analyses were performed to summarize the findings. While 96% of participants reported routine pre-HSCT psychosocial assessment of patients, only 10.6% routinely used a validated transplant risk-assessment measure. Just 27% routinely performed follow-up psychosocial assessments. In contrast, only 47% of participants routinely assessed the psychosocial needs of family caregivers pre-HSCT, and 13% routinely performed follow-up assessments for caregivers. Most (90%) reported social workers were the primary providers of assessments. While patient-report measures were used for evaluation, the majority of assessments were clinical interviews. No significant differences were found between programs that treated adult and pediatric patients versus those only treating adult patients. Our findings highlight the lack of standard psychosocial practices for patients and family caregivers undergoing HSCT and we offer recommendations to fill this gap.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The datasets generated during and analyzed during the current study are available from the corresponding author upon reasonable request.
References
Snowden JA, Sánchez-Ortega I, Corbacioglu S, Basak GW, Chabannon C, de la Camara R, et al. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transplant. 2022;57:1217–39. https://doi.org/10.1038/s41409-022-01691-w.
Kroemeke A, Sobczyk-Kruszelnicka M, Kwissa-Gajewska Z. Everyday life following hematopoietic stem cell transplantation: decline in physical symptoms within the first month and change-related predictors. Qual Life Res. 2018;27:125–35. https://doi.org/10.1007/s11136-017-1705-3.
Khera N. Managing survivorship after hematopoietic cell transplantation. Curr Hematol Malig Rep. 2023;18:75–82. https://doi.org/10.1007/s11899-023-00694-8.
Bevans M, El-Jawahri A, Tierney DK, Wiener L, Wood WA, Hoodin F, et al. National Institutes of Health hematopoietic cell transplantation late effects initiative: the patient-centered outcomes working group report. Biol Blood Marrow Transplant. 2017;23:538–51. https://doi.org/10.1016/j.bbmt.2016.09.011.
Mitchell SA, Wiener L, Hoag J, Fry A, Bevans MF. Quality of life in adult and pediatric survivors of stem cell transplantation. In: Savani BN, Tichelli A, editors. Blood and Marrow Transplantation Long Term Management: Survivorship after Transplant 2nd ed. West Sussex, UK: Wiley; 2021. pp. 355–383.
Amonoo HL, Massey CN, Freedman ME, El-Jawahri A, Vitagliano HL, Pirl WF, et al. Psychological considerations in hematopoietic stem cell transplantation. Psychosomatics. 2019;60:331–42. https://doi.org/10.1016/j.psym.2019.02.004.
Amonoo HL, Markovitz NH, Johnson PC, Kwok A, Dale C, Deary EC, et al. Delirium and healthcare utilization in patients undergoing hematopoietic stem cell transplantation. Transplant Cell Ther. 2023;29:334.e1–7. https://doi.org/10.1016/j.jtct.2023.01.028.
El-Jawahri AR, Vandusen HB, Traeger LN, Fishbein JN, Keenan T, Gallagher ER, et al. Quality of life and mood predict posttraumatic stress disorder after hematopoietic stem cell transplantation. Cancer. 2016;122:806–12. https://doi.org/10.1002/cncr.29818.
El-Jawahri AR, Traeger LN, Kuzmuk K, Eusebio JR, Vandusen HB, Shin JA, et al. Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation. Cancer. 2015;121:951–9. https://doi.org/10.1002/cncr.29149.
Pirl WF, Fann JR, Greer JA, Braun I, Deshields T, Fulcher C, et al. Recommendations for the implementation of distress screening programs in cancer centers: report from the American Psychosocial Oncology Society (APOS), Association of Oncology Social Work (AOSW), and Oncology Nursing Society (ONS) joint task force. Cancer. 2014;120:2946–54. https://doi.org/10.1002/cncr.28750.
Bevans M, Wehrlen L, Prachenko O, Soeken K, Zabora J, Wallen GR. Distress screening in allogeneic hematopoietic stem cell (HSCT) caregivers and patients. Psychooncology. 2011;20:615–22. https://doi.org/10.1002/pon.1906.
McFarland D, Gorman E, Kim S, Rothwell A, Saunders P, Tindle S, et al. Psychiatric evaluations prior to stem cell transplant – a survey of National Marrow Donor Programs. Psychooncology. 2016;25:877–9. https://doi.org/10.1002/pon.3955.
Randall J, Anderson G, Kayser K. Psychosocial assessment of candidates for hematopoietic cell transplantation: a national survey of centers’ practices. Psychooncology. 2022;31:1253–60. https://doi.org/10.1002/pon.5919.
Solh MM, Speckhart D, Solomon SR, Bashey A, Morris LE, Zhang X, et al. The Transplant Evaluation Rating Scale predicts overall survival after allogeneic hematopoietic stem cell transplantation. Blood Adv. 2020;4:4812–21. https://doi.org/10.1182/bloodadvances.2020002204.
Richardson DR, Huang Y, McGinty HL, Elder P, Newlin J, Kirkendall C, et al. Psychosocial risk predicts high readmission rates for hematopoietic cell transplant recipients. Bone Marrow Transplant. 2018;53:1418–27. https://doi.org/10.1038/s41409-018-0118-4.
Hoodin F, Kalbfleisch KR. Factor analysis and validity of the Transplant Evaluation Rating Scale in a large bone marrow transplant sample. J Psychosom Res. 2003;54:465–73. https://doi.org/10.1016/s0022-3999(02)00413-0.
Hoodin F, Kalbfleisch KR, Thornton J, Ratanatharathorn V. Psychosocial influences on 305 adults’ survival after bone marrow transplantation; depression, smoking, and behavioral self-regulation. J Psychosom Res. 2004;57:145–54. https://doi.org/10.1016/S0022-3999(03)00599-3.
Brewer B, Sharma P, Gakhar N, Sannes TS, Joshi TK, Hunter R, et al. Quality of life following cord blood versus matched sibling donor transplantation: pre-transplantation psychiatric and socioeconomic factors significantly impact outcomes. Bone Marrow Transplant. 2022;57:1344–6. https://doi.org/10.1038/s41409-022-01721-7.
Mumby PB, Doyle T, Adams W, Hicks EB, Thilges S, Mai HP, et al. Utility of the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in hematopoietic stem cell transplantation (HSCT). J Clin Oncol. 2017;35(15_suppl):10046. https://doi.org/10.1200/JCO.2017.35.15_suppl.10046.
Mishkin AD, Shapiro PA, Reshef R, Lopez-Pintado S, Mapara MY. Standardized semi-structured psychosocial evaluation before hematopoietic stem cell transplantation predicts patient adherence to post-transplant regimen. Biol Blood Marrow Transplant. 2019;25:2222–7. https://doi.org/10.1016/j.bbmt.2019.06.019.
Mishkin AD, Schmajuk M, Reshef R, Lopez-Pintado S, Mapara MY, Shapiro PA. Standardized semistructured psychosocial evaluation before stem cell transplantation predicts delirium after transplant. J Acad Consult Liaison Psychiatry. 2021;62:440–4. https://doi.org/10.1016/j.jaclp.2020.12.004.
Hong S, Rybicki L, Corrigan D, Dabney J, Hamilton BK, Kalaycio M, et al. Psychosocial Assessment of Candidates for Transplant (PACT) as a tool for psychological and social evaluation of allogeneic hematopoietic cell transplantation recipients. Bone Marrow Transplant. 2019;54:1443–52. https://doi.org/10.1038/s41409-019-0455-y.
Scherer S, Scheid C, von Bergwelt M, Hellmich M, Albus C, Vitinius F. Psychosocial pre-transplant screening with the transplant evaluation rating scale contributes to prediction of survival after hematopoietic stem cell transplantation. Front Psychiatry. 2021;12:741438 https://doi.org/10.3389/fpsyt.2021.741438.
Frey P, Stinson T, Siston A, Knight SJ, Ferdman E, Traynor A, et al. Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program. Bone Marrow Transplant. 2002;30:741–8. https://doi.org/10.1038/sj.bmt.1703676.
Volpp KG, Diamond SM, Shrank WH. Innovation in home care: time for a new payment model. JAMA. 2020;323:2474–5. https://doi.org/10.1001/jama.2020.1036.
Applebaum AJ, Sannes T, Mitchell HR, McAndrew NS, Wiener L, Knight JM, et al. Fit for duty: lessons learned from outpatient and homebound hematopoietic cell transplantation to prepare family caregivers for home-based care. Transpl Cell Ther. 2023;29:143–50. https://doi.org/10.1016/j.jtct.2022.12.014.
Sannes TS, Ranby KW, Yusufov M, Brewer BW, Jacobs JM, Callan S, et al. More often than not, we’re in sync: patient and caregiver well-being over time in stem cell transplantation. Health Qual Life Outcomes. 2022;20:6 https://doi.org/10.1186/s12955-021-01909-3.
Sannes TS, Simoneau TL, Mikulich-Gilbertson SK, Natvig CL, Brewer BW, Kilbourn K, et al. Distress and quality of life in patient and caregiver dyads facing stem cell transplant: identifying overlap and unique contributions. Support Care Cancer. 2019;27:2329–37. https://doi.org/10.1007/s00520-018-4496-3.
Geng HM, Chuang DM, Yang F, Yang Y, Liu WM, Liu LH, et al. Prevalence and determinants of depression in caregivers of cancer patients: a systematic review and meta-analysis. Medicine (Baltimore). 2018;97:e11863. https://doi.org/10.1097/MD.0000000000011863.
Jadalla A, Ginex P, Coleman M, Vrabel M, Bevans M. Family caregiver strain and burden: a systematic review of evidence-based interventions when caring for patients with cancer. Clin J Oncol Nurs. 2020;24:31–50. https://doi.org/10.1188/20.CJON.31-50.
Shokri M, Tarjoman A, Borji M, Solaimanizadeh L. Investigating psychological problems in caregiver of pediatrics with cancer: a systematic review. J Child Adolesc Psychiatr Nurs. 2020;33:229–38. https://doi.org/10.1111/jcap.12269.
Randall J, Miller JJ. A conceptual framework of the psychosocial elements that should be assessed in candidates for hematopoietic cell transplant: social workers’ and psychologists’ perspectives. J Psychosoc Oncol. 2023;41:303–20. https://doi.org/10.1080/07347332.2022.2104677.
Cooke L, Gemmill R, Kravits K, Grant M. Psychological issues of stem cell transplant. Semin Oncol Nurs. 2009;25:139–50. https://doi.org/10.1016/j.soncn.2009.03.008.
Bevans MF, Mitchell SA, Marden S. The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT). Support Care Cancer. 2008;16:1243–54. https://doi.org/10.1007/s00520-008-0420-6.
Gomez-Bernal F, Madva EN, Puckett J, Amonoo HL, Millstein RA, Huffman JC. Relationships between life stressors, health behaviors, and chronic medical conditions in mid-life adults: a narrative review. Psychosomatics. 2019;60:153–63. https://doi.org/10.1016/j.psym.2018.12.007.
Deshields T, Asvat Y. The case for accelerating integrated mental health care in the cancer setting. JCO Oncol Pract. 2023;19:231–33. https://doi.org/10.1200/op.22.00840.
Stickney Ferguson S, Randall J, Dabney J, Kalbacker ME, Boyle N, Thao V, et al. Perceived workforce challenges among clinical social workers in hematopoietic cell transplantation programs. Biol Blood Marrow Transplant. 2018;24:1063–8. https://doi.org/10.1016/j.bbmt.2017.12.793.
Dignan FL, Hamblin A, Chong A, Lee J, Kenyon M, Miller P, et al. Survivorship care for allogeneic transplant patients in the UK NHS: changes centre practice, impact of health service policy and JACIE accreditation over 5 years. Bone Marrow Transplant. 2021;56:673–8. https://doi.org/10.1038/s41409-020-01067-y.
Myrvik M, Beverung L, Panepinto J, Igler E, Englebert N, Bingen K. Integration of Electronic Patient-Reported Outcomes (ePROs) into pediatric clinic settings across hematology/oncology/bone marrow transplant. Clin Pract Pediatr Psychol. 2014;2:39 https://doi.org/10.1037/cpp0000052.
Palos GR, Gilmore KR, Chapman PH, Rodriguez MA. Implementation of ePROs in the care of long-term cancer survivors. J Clin Oncol. 2021;39(28_suppl):334. https://doi.org/10.1200/JCO.2020.39.28_suppl.334.
Cusatis R, Flynn KE, Vasu S, Pidala J, Muffly L, Uberti J, et al. Adding centralized electronic patient-reported outcome data collection to an established international clinical outcomes registry. Transpl Cell Ther. 2022;28:e9. https://doi.org/10.1016/j.jtct.2021.10.016.
Denis F, Krakowski I. How should oncologists choose an electronic patient-reported outcome system for remote monitoring of patients with cancer? J Med Internet Res. 2021;23:e30549. https://doi.org/10.2196/30549.
Kiderlen TR, Schnack A, de Wit M. Essential barriers and considerations for the implementation of electronic patient-reported outcome (ePRO) measures in oncological practice: contextualizing the results of a feasibility study with existing literature. Z Gesundh Wiss. 2022:1–18. https://doi.org/10.1007/s10389-022-01767-3.
Patt D, Wilfong L, Hudson KE, Patel A, Books H, Pearson B, et al. Implementation of electronic patient-reported outcomes for symptom monitoring in a large multisite community oncology practice: dancing the texas two-step through a pandemic. JCO Clin Cancer Inform. 2021;5:615–21. https://doi.org/10.1200/cci.21.00063.
Shaw BE, Brazauskas R, Millard HR, Fonstad R, Flynn KE, Abernethy A, et al. Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful. Cancer. 2017;123:4687–700. https://doi.org/10.1002/cncr.30936.
Costanzo ES, Juckett MB, Coe CL. Biobehavioral influences on recovery following hematopoietic stem cell transplantation. Brain Behav Immun. 2013;30(Suppl):S68–74. https://doi.org/10.1016/j.bbi.2012.07.005.
El-Jawahri A, Chen YB, Brazauskas R, He N, Lee SJ, Knight JM, et al. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation. Cancer. 2017;123:1828–38. https://doi.org/10.1002/cncr.30546.
Hoodin F, Uberti JP, Lynch TJ, Steele P, Ratanatharathorn V. Do negative or positive emotions differentially impact mortality after adult stem cell transplant? Bone Marrow Transplant. 2006;38:255–64. https://doi.org/10.1038/sj.bmt.1705419.
Wallston KA, Wallston BS, DeVellis R. Development of the Multidimensional Health Locus of Control (MHLC) scales. Health Educ Monogr. 1978;6:160–70. https://doi.org/10.1177/109019817800600107.
Applebaum AJ, Kent EE, Lichtenthal WG. Documentation of caregivers as a standard of care. J Clin Oncol. 2021;39:1955–8. https://doi.org/10.1200/JCO.21.00402.
Elko TA, Brown S, Lobaugh S, Devlin S, Jakubowski AA, Perales MA, et al. Characteristics of distress and support group participation in caregivers of older allogeneic hematopoietic cell transplantation patients: a single institution retrospective review. J Adv Pract Oncol. 2023;14:127–37. https://doi.org/10.6004/jadpro.2023.14.2.3.
Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, et al. Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017;35:96–112. https://doi.org/10.1200/jco.2016.70.1474.
Greer JA, Applebaum AJ, Jacobsen JC, Temel JS, Jackson VA. Understanding and addressing the role of coping in palliative care for patients with advanced cancer. J Clin Oncol. 2020;38:915–25. https://doi.org/10.1200/jco.19.00013.
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733–42. https://doi.org/10.1056/NEJMoa1000678.
Temel JS, Petrillo LA, Greer JA. Patient-centered palliative care for patients with advanced lung cancer. J Clin Oncol. 2022;40:626–34. https://doi.org/10.1200/jco.21.01710.
El-Jawahri A, LeBlanc T, VanDusen H, Traeger L, Greer JA, Pirl WF, et al. Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial. JAMA. 2016;316:2094–103. https://doi.org/10.1001/jama.2016.16786.
El-Jawahri A, LeBlanc TW, Kavanaugh A, Webb JA, Jackson VA, Campbell TC, et al. Effectiveness of integrated palliative and oncology care for patients with acute myeloid leukemia: a randomized clinical trial. JAMA Oncol. 2021;7:238–45. https://doi.org/10.1001/jamaoncol.2020.6343.
LeBlanc TW, Roeland EJ, El-Jawahri A. Early palliative care for patients with hematologic malignancies: is it really so difficult to achieve? Curr Hematol Malig Rep. 2017;12:300–8. https://doi.org/10.1007/s11899-017-0392-z.
Mekelenkamp H, Schröder T, Trigoso E, Hutt D, Galimard J-E, Kozijn A, et al. Specialized pediatric palliative care services in pediatric hematopoietic stem cell transplant centers. Children. 2021;8:615.
El-Jawahri A, Nelson AM, Gray TF, Lee SJ, LeBlanc TW. Palliative and end-of-life care for patients with hematologic malignancies. J Clin Oncol. 2020;38:944–53. https://doi.org/10.1200/jco.18.02386.
Phipps S, Rai SN, Leung W-H, Lensing S, Dunavant M. Cognitive and academic consequences of stem-cell transplantation in children. J Clin Oncol. 2008;25:2027–33. https://doi.org/10.1200/jco.2007.13.6135.
Pennarola BW, Fry A, Prichett L, Beri AE, Shah NN, Wiener L. Mapping the landscape of advance care planning in adolescents and young adults receiving allogeneic hematopoietic stem cell transplantation: a 5-year retrospective review. Transpl Cell Ther. 2022;28:164.e1–8. https://doi.org/10.1016/j.jtct.2021.12.007.
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9. https://doi.org/10.1111/j.1532-5415.2005.53221.x.
Bohn MJ, Babor TF, Kranzler HR. The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol. 1995;56:423–32. https://doi.org/10.15288/jsa.1995.56.423.
Carver CS. You want to measure coping but your protocol’s too long: consider the brief COPE. Int J Behav Med. 1997;4:92–100. https://doi.org/10.1207/s15327558ijbm0401_6.
McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A, et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant. 1997;19:357–68. https://doi.org/10.1038/sj.bmt.1700672.
Cutillo A, O’Hea E, Person S, Lessard D, Harralson T, Boudreaux E. The distress thermometer: cutoff points and clinical use. Oncol Nurs Forum. 2017;44:329–36. https://doi.org/10.1188/17.onf.329-336.
Patel MR, Zhang G, Heisler M, Song P, Piette JD, Shi X, et al. Measurement and validation of the Comprehensive Score for Financial Toxicity (COST) in a population with diabetes. Diabetes Care. 2022;45:2535–43. https://doi.org/10.2337/dc22-0494.
Dykhuis KE, Slowik L, Bryce K, Hyde-Nolan ME, Eshelman A, Miller-Matero LR. A new measure of health numeracy: Brief Medical Numbers Test (BMNT). Psychosomatics. 2019;60:271–7. https://doi.org/10.1016/j.psym.2018.07.004.
Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–7. https://doi.org/10.1037/0022-006X.56.6.893.
Pozueta A, Rodríguez-Rodríguez E, Vazquez-Higuera JL, Mateo I, Sánchez-Juan P, González-Perez S, et al. Detection of early Alzheimer’s disease in MCI patients by the combination of MMSE and an episodic memory test. BMC Neurol. 2011;11:78. https://doi.org/10.1186/1471-2377-11-78.
Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998;28:551–8. https://doi.org/10.1017/s0033291798006667.
Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care. 1999;37:126–39. https://doi.org/10.1097/00005650-199902000-00003.
Alderfer MA, Mougianis I, Barakat LP, Beele D, DiTaranto S, Hwang WT, et al. Family psychosocial risk, distress, and service utilization in pediatric cancer: predictive validity of the Psychosocial Assessment Tool. Cancer. 2009;115:4339–49. https://doi.org/10.1002/cncr.24587.
Wood DL, Sawicki GS, Miller MD, Smotherman C, Lukens-Bull K, Livingood WC, et al. The Transition Readiness Assessment Questionnaire (TRAQ): its factor structure, reliability, and validity. Acad Pediatr. 2014;14:415–22. https://doi.org/10.1016/j.acap.2014.03.008.
Tomlinson D, Dupuis LL, Gibson P, Johnston DL, Portwine C, Baggott C, et al. Initial development of the Symptom Screening in Pediatrics Tool (SSPedi). Support Care Cancer. 2014;22:71–5. https://doi.org/10.1007/s00520-013-1945-x.
Na SD, Burns TG. Wechsler Intelligence Scale for Children-V: test review. Appl Neuropsychol Child. 2016;5:156–60. https://doi.org/10.1080/21622965.2015.1015337.
Climie EA, Rostad K. Test review: Wechsler Adult Intelligence Scale. J Psychoeduc Assess. 2011;29:581–6. https://doi.org/10.1177/0734282911408707.
Altmann RA, Reynolds CR, Kamphaus RW, Vannest KJ. BASC-3. In: Kreutzer J, DeLuca J, Caplan B, editors. Encyclopedia of clinical neuropsychology. Springer: International Publishing; 2017. p. 1–7.
Acknowledgements
We wish to acknowledge the American Psychosocial Oncology Society (APOS), formed in 1986 to bring together interdisciplinary professionals working on the psychological, behavioral, and social aspects of cancer. APOS’s mission is to advance the development and delivery of equitable and evidence-based psychosocial oncology care through research, practice, education, and advocacy. This work was conducted within APOS’s Transplantation and Cellular Therapy (TCT) Special Interest Group. We also wish to acknowledge all those persons who have gone through HSCT and their caregivers, as well as their healthcare providers, for inspiring this work.
Funding
This work was supported (in part) by the Intramural Program of the National Cancer Institute (LW) and through grant K08CA251654 (HLA). JR received research support from the National Cancer Institute institutional training grant T32-CA-236621.
Author information
Authors and Affiliations
Contributions
LW, HLA, TSS, and JR conceptualized the idea and participated in the acquisition of data. LW wrote the original draft with contributions from BWB, SL, JR, AJA, TFG, NSM, HLA, and TSS participated in data analysis and manuscript writing. All authors reviewed and edited the final submitted manuscript.
Corresponding author
Ethics declarations
Competing interests
All other authors report no other conflicts of interest. AJA receives support from Blue Note Therapeutics and Beigene.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Wiener, L., Sannes, T.S., Randall, J. et al. Psychosocial assessment practices for hematopoietic stem cell transplantation: a national survey study. Bone Marrow Transplant 58, 1314–1321 (2023). https://doi.org/10.1038/s41409-023-02087-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-023-02087-0